Skip to content
Home/Companies/Pharma/Develco Pharma
Develco Pharma

Develco Pharma

Pharma·Switzerland·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Develco Pharma?

Develco Pharma is currently owned by SHS Gesellschaft für Beteiligungsmanagement through SHS V (2018 vintage), since 2020.

Hand-verified · updated 2026-08-10

SHS Gesellschaft für Beteiligungsmanagement
Investor
SHS Gesellschaft für Beteiligungsmanagement
SHS V · 2018 · Buyout

Key facts

HQSwitzerland
SectorPharma
StatusActive
Websitewww.develco.ch

More from SHS V

Other portfolio companies in the same fund.

Dr.Dropin
Dr.Dropin
Active
HealthcareNorway· 2022
Lowenco
Lowenco
Active
MedTechDenmark· 2022
Blue Ocean Spine
Blue Ocean Spine
Active
MedTechGermany· 2021
Incision
Incision
Active
HealthTechNetherlands· 2021
PathoQuest
PathoQuest
Exited 2026
BiotechFrance· 2021
to
Blazejewski MEDI-TECH
Blazejewski MEDI-TECH
Exited 2022
MedTechGermany· 2020
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
Cinclus Pharma
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
InfoRLife
Active
BC PartnersSwitzerland· 2026
IRAB
IRAB
Active
ARCHIMEDSpain· 2026
Neftys Pharma
Neftys Pharma
Active
UI InvestissementFrance· 2026
Revi Pharma
Revi Pharma
Active
AVM SGRItaly· 2026
Track Develco Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Develco Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue